| Dr Charles L Tucker, MD | |
|
195 Hospital Dr, Cherokee Village, AR 72529-7314 | |
| (870) 257-6060 | |
| (870) 257-7667 |
| Full Name | Dr Charles L Tucker |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 63 Years |
| Location | 195 Hospital Dr, Cherokee Village, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639173396 | NPI | - | NPPES |
| 105959001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | C3379 (Arkansas) | Primary |
| Entity Name | Bhg L Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699321406 PECOS PAC ID: 0547699225 Enrollment ID: O20200331003025 |
News Archive
Curcumin, the main compound in the spice turmeric, prevents replication of mosquito-borne Rift Valley Fever virus in infected cells, report researchers.
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.
Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.
BioDelivery Sciences International, Inc. announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled.
› Verified 1 days ago
| Entity Name | Cross Hope Treatment Centers, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922675685 PECOS PAC ID: 7618374802 Enrollment ID: O20210930003177 |
News Archive
Curcumin, the main compound in the spice turmeric, prevents replication of mosquito-borne Rift Valley Fever virus in infected cells, report researchers.
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.
Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.
BioDelivery Sciences International, Inc. announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles L Tucker, MD 195 Hospital Dr, Cherokee Village, AR 72529-7314 Ph: (870) 257-6061 | Dr Charles L Tucker, MD 195 Hospital Dr, Cherokee Village, AR 72529-7314 Ph: (870) 257-6060 |
News Archive
Curcumin, the main compound in the spice turmeric, prevents replication of mosquito-borne Rift Valley Fever virus in infected cells, report researchers.
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.
Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.
BioDelivery Sciences International, Inc. announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled.
› Verified 1 days ago
Timothy Young, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Hospital Drive, Suite B, Cherokee Village, AR 72529 Phone: 870-257-6000 Fax: 870-257-7673 | |
Dr. Denise T Oldenberg, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 West Cherokee Village Mall, Cherokee Village, AR 72529 Phone: 870-257-4110 Fax: 870-257-4112 | |
Lauren Elizabeth Bloch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Hospital Dr Ste B, Cherokee Village, AR 72529 Phone: 870-257-6060 | |
Terry L Burns, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Hospital Drive, Suite A, Cherokee Village, AR 72529 Phone: 870-257-6060 Fax: 870-257-7664 |